Review



rabbit polyclonal ifitm1 antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech rabbit polyclonal ifitm1 antibody
    Rabbit Polyclonal Ifitm1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 35 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal ifitm1 antibody/product/Proteintech
    Average 93 stars, based on 35 article reviews
    rabbit polyclonal ifitm1 antibody - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    94
    Bioss rabbit anti ifitm1
    Primer sequences for RT-qPCR
    Rabbit Anti Ifitm1, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti ifitm1/product/Bioss
    Average 94 stars, based on 1 article reviews
    rabbit anti ifitm1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    93
    Proteintech rabbit polyclonal ifitm1 antibody
    Primer sequences for RT-qPCR
    Rabbit Polyclonal Ifitm1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal ifitm1 antibody/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal ifitm1 antibody - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc polyclonal rabbit anti-ifitm1 antibody
    Primer sequences for RT-qPCR
    Polyclonal Rabbit Anti Ifitm1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti-ifitm1 antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-ifitm1 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Affinity Biosciences rabbit polyclonal antibody against ifitm1
    Pseudo-time analysis of KC and impaired epidermal differentiation in DFU. ( a ) Pseudo-temporal cells ordering of the total KC along the differentiation trajectory. ( b ) Pseudo-temporal cell ordering of KC in AW along the differentiation trajectory. ( c ) Pseudo-temporal cell ordering of the KC in the DFU along the differentiation trajectory. The pseudo-time data are depicted in dark purple to light yellow ( d ) The expression levels of the marker genes COL17A1, KRT14, FOS, <t>IFITM1,</t> S100A7, KRT6C, KRT1, and KRT10 along the pseudo-time trajectory. ( e ) UMAP analysis of the cell cycle distribution of KC at different stages. The cells are colored by type and annotated in the graph. ( f ) S score of each KC cluster. ( g ) G2M. Score of each KC cluster. * p -value <0.05. ( h ) Gene scoring analysis of the molecular signatures, including the Q score, diff score and inflammatory score. * p <0.05, ** p e <0.01, (ns) p >0.05. ( i ) Schematic of epidermal cell differentiation trajectories in AW and DFU. Quiescent score (Q score), differentiated score (diff score), basal cells (BC), diabetes-associated keratinocytes (DAK), and differentiated keratinocytes (diff-KC)
    Rabbit Polyclonal Antibody Against Ifitm1, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against ifitm1/product/Affinity Biosciences
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibody against ifitm1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc polyclonal rabbit anti ifitm1
    Pseudo-time analysis of KC and impaired epidermal differentiation in DFU. ( a ) Pseudo-temporal cells ordering of the total KC along the differentiation trajectory. ( b ) Pseudo-temporal cell ordering of KC in AW along the differentiation trajectory. ( c ) Pseudo-temporal cell ordering of the KC in the DFU along the differentiation trajectory. The pseudo-time data are depicted in dark purple to light yellow ( d ) The expression levels of the marker genes COL17A1, KRT14, FOS, <t>IFITM1,</t> S100A7, KRT6C, KRT1, and KRT10 along the pseudo-time trajectory. ( e ) UMAP analysis of the cell cycle distribution of KC at different stages. The cells are colored by type and annotated in the graph. ( f ) S score of each KC cluster. ( g ) G2M. Score of each KC cluster. * p -value <0.05. ( h ) Gene scoring analysis of the molecular signatures, including the Q score, diff score and inflammatory score. * p <0.05, ** p e <0.01, (ns) p >0.05. ( i ) Schematic of epidermal cell differentiation trajectories in AW and DFU. Quiescent score (Q score), differentiated score (diff score), basal cells (BC), diabetes-associated keratinocytes (DAK), and differentiated keratinocytes (diff-KC)
    Polyclonal Rabbit Anti Ifitm1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti ifitm1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    polyclonal rabbit anti ifitm1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Proteintech mabe1095 rabbit polyclonal anti ifitm1 proteintech 60074 1 ig rabbit monoclonal anti cgas cst 79978s rabbit monoclonal anti marcks cst
    Pseudo-time analysis of KC and impaired epidermal differentiation in DFU. ( a ) Pseudo-temporal cells ordering of the total KC along the differentiation trajectory. ( b ) Pseudo-temporal cell ordering of KC in AW along the differentiation trajectory. ( c ) Pseudo-temporal cell ordering of the KC in the DFU along the differentiation trajectory. The pseudo-time data are depicted in dark purple to light yellow ( d ) The expression levels of the marker genes COL17A1, KRT14, FOS, <t>IFITM1,</t> S100A7, KRT6C, KRT1, and KRT10 along the pseudo-time trajectory. ( e ) UMAP analysis of the cell cycle distribution of KC at different stages. The cells are colored by type and annotated in the graph. ( f ) S score of each KC cluster. ( g ) G2M. Score of each KC cluster. * p -value <0.05. ( h ) Gene scoring analysis of the molecular signatures, including the Q score, diff score and inflammatory score. * p <0.05, ** p e <0.01, (ns) p >0.05. ( i ) Schematic of epidermal cell differentiation trajectories in AW and DFU. Quiescent score (Q score), differentiated score (diff score), basal cells (BC), diabetes-associated keratinocytes (DAK), and differentiated keratinocytes (diff-KC)
    Mabe1095 Rabbit Polyclonal Anti Ifitm1 Proteintech 60074 1 Ig Rabbit Monoclonal Anti Cgas Cst 79978s Rabbit Monoclonal Anti Marcks Cst, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mabe1095 rabbit polyclonal anti ifitm1 proteintech 60074 1 ig rabbit monoclonal anti cgas cst 79978s rabbit monoclonal anti marcks cst/product/Proteintech
    Average 94 stars, based on 1 article reviews
    mabe1095 rabbit polyclonal anti ifitm1 proteintech 60074 1 ig rabbit monoclonal anti cgas cst 79978s rabbit monoclonal anti marcks cst - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Millipore rabbit anti-ifitm1 polyclonal antibody
    Upregulation of IFITMs in HTR8/SVneo cells following IFN-β treatment was evaluated by western blot and immunofluorescence IFN-β inhibits invasion of HTR8/SVneo cells (A–E) and primary human EVCTs (F–I). HTR8/SVneo cells and EVCTs were incubated for 48 h with IFN-β (10, 100, or 1000 IU/mL). (A) Cell lysates (40 μg) were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for <t>IFITM1,</t> IFITM2/3, and vinculin expression. One representative experiment (out of 3) is shown. (B) Representative image of HTR8/SVneo cells immunostained for cytokeratin 7 (marker of trophoblast, magenta) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bars: 10 μm. Inhibition of HTR8/SVneo cell invasion following IFN-β treatment , quantified using IncuCyte technology (C–E) . HTR8/SVneo cells were cultured in a monolayer in 96-well plates. Cells were treated for 48 h, then a wound was made using a 96-well wound maker; this was covered by Matrigel and cells were imaged with Incucyte every 30 min for 48 h. (C) Representative images of HTR8/SVneo cell invasion at 48 h. The blue region denotes the area of the initial wound (light blue line) covered by advancing cells. (D) Time course of wound closure expressed as relative wound density (%). Values are reported as mean ± SEM. (E) Comparison between vehicle and IFN-β-treated cells was performed using an analysis of the area under the curve of the replicates represented in (D). Values are reported as mean + SEM (n = 6 wells/condition, n = 3 experiments). Statistical analysis was performed with one-way ANOVA to compare treatment to vehicle controls. ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. Upregulation of IFITMs in EVCTs following IFN-β treatment was evaluated by western blot (F) and immunofluorescence (G) . (F) Cell lysates (40 μg) from isolated EVCTs were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for IFITM1, IFITM2/3, and vinculin expression. One representative experiment (out of 3) is shown. (G) Representative image of isolated EVCTs and placental explants immunostained for cytokeratin 7 (marker of trophoblast, magenta) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bars: 10 μm. Inhibition of EVCT invasion following IFN-β treatment using villous explant culture model (H–I) . (H) Representative image of extravillous explants cultured on Matrigel and immunostained for integrin α5 (ITGA5, marker of invasion, red). Scale bars: 100 μm. (I) Statistical analysis of the invasion distance of ITGA5 + EVCTs, as representatively shown in H. Values are presented as mean + SD (n = 3 explants per condition, n = 3 placentas). One-way ANOVA was performed to compare treatment to vehicle control; ∗∗∗∗p < 0.0001.
    Rabbit Anti Ifitm1 Polyclonal Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-ifitm1 polyclonal antibody/product/Millipore
    Average 90 stars, based on 1 article reviews
    rabbit anti-ifitm1 polyclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    91
    Atlas Antibodies rabbit polyclonal anti ifitm1 antibody
    Upregulation of IFITMs in HTR8/SVneo cells following IFN-β treatment was evaluated by western blot and immunofluorescence IFN-β inhibits invasion of HTR8/SVneo cells (A–E) and primary human EVCTs (F–I). HTR8/SVneo cells and EVCTs were incubated for 48 h with IFN-β (10, 100, or 1000 IU/mL). (A) Cell lysates (40 μg) were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for <t>IFITM1,</t> IFITM2/3, and vinculin expression. One representative experiment (out of 3) is shown. (B) Representative image of HTR8/SVneo cells immunostained for cytokeratin 7 (marker of trophoblast, magenta) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bars: 10 μm. Inhibition of HTR8/SVneo cell invasion following IFN-β treatment , quantified using IncuCyte technology (C–E) . HTR8/SVneo cells were cultured in a monolayer in 96-well plates. Cells were treated for 48 h, then a wound was made using a 96-well wound maker; this was covered by Matrigel and cells were imaged with Incucyte every 30 min for 48 h. (C) Representative images of HTR8/SVneo cell invasion at 48 h. The blue region denotes the area of the initial wound (light blue line) covered by advancing cells. (D) Time course of wound closure expressed as relative wound density (%). Values are reported as mean ± SEM. (E) Comparison between vehicle and IFN-β-treated cells was performed using an analysis of the area under the curve of the replicates represented in (D). Values are reported as mean + SEM (n = 6 wells/condition, n = 3 experiments). Statistical analysis was performed with one-way ANOVA to compare treatment to vehicle controls. ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. Upregulation of IFITMs in EVCTs following IFN-β treatment was evaluated by western blot (F) and immunofluorescence (G) . (F) Cell lysates (40 μg) from isolated EVCTs were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for IFITM1, IFITM2/3, and vinculin expression. One representative experiment (out of 3) is shown. (G) Representative image of isolated EVCTs and placental explants immunostained for cytokeratin 7 (marker of trophoblast, magenta) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bars: 10 μm. Inhibition of EVCT invasion following IFN-β treatment using villous explant culture model (H–I) . (H) Representative image of extravillous explants cultured on Matrigel and immunostained for integrin α5 (ITGA5, marker of invasion, red). Scale bars: 100 μm. (I) Statistical analysis of the invasion distance of ITGA5 + EVCTs, as representatively shown in H. Values are presented as mean + SD (n = 3 explants per condition, n = 3 placentas). One-way ANOVA was performed to compare treatment to vehicle control; ∗∗∗∗p < 0.0001.
    Rabbit Polyclonal Anti Ifitm1 Antibody, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti ifitm1 antibody/product/Atlas Antibodies
    Average 91 stars, based on 1 article reviews
    rabbit polyclonal anti ifitm1 antibody - by Bioz Stars, 2026-03
    91/100 stars
      Buy from Supplier

    Image Search Results


    Primer sequences for RT-qPCR

    Journal: Intractable & Rare Diseases Research

    Article Title: The novel role of IFITM1-3 in myogenic differentiation of C2C12 cells

    doi: 10.5582/irdr.2023.01050

    Figure Lengend Snippet: Primer sequences for RT-qPCR

    Article Snippet: The membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.1% Tween 20 (TBST) for 2 h at room temperature, and then the membranes were incubated with primary antibodies, namely, rabbit anti-desmin (ab32362, Abcam, USA), rabbit anti-MyoD (ab203383, Abcam, USA), rabbit anti-MYF5 (ab125301, Abcam, USA), rabbit anti-IFITM1 (bs-1031R, Bioss, China), rabbit anti-IFITM2 (bs-15517R, Bioss, China), mouse anti-IFITM3 (bsm-51629M, Bioss, China), and rabbit anti-GAPDH (ab8245, Abcam, USA), at 4°C overnight.

    Techniques: Sequencing

    Increased expression of IFITM1-3 during myogenic differentiation of C2C12 myoblasts. (A) Relative expression of Ifitm1-3 during the myogenic differentiation process. (B) Western blot evaluating the protein levels of IFITM1-3. (C) Quantification of band intensity as described above is shown. The level of proteins was normalized to that of GAPDH. Statistical significance: *P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant.

    Journal: Intractable & Rare Diseases Research

    Article Title: The novel role of IFITM1-3 in myogenic differentiation of C2C12 cells

    doi: 10.5582/irdr.2023.01050

    Figure Lengend Snippet: Increased expression of IFITM1-3 during myogenic differentiation of C2C12 myoblasts. (A) Relative expression of Ifitm1-3 during the myogenic differentiation process. (B) Western blot evaluating the protein levels of IFITM1-3. (C) Quantification of band intensity as described above is shown. The level of proteins was normalized to that of GAPDH. Statistical significance: *P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant.

    Article Snippet: The membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.1% Tween 20 (TBST) for 2 h at room temperature, and then the membranes were incubated with primary antibodies, namely, rabbit anti-desmin (ab32362, Abcam, USA), rabbit anti-MyoD (ab203383, Abcam, USA), rabbit anti-MYF5 (ab125301, Abcam, USA), rabbit anti-IFITM1 (bs-1031R, Bioss, China), rabbit anti-IFITM2 (bs-15517R, Bioss, China), mouse anti-IFITM3 (bsm-51629M, Bioss, China), and rabbit anti-GAPDH (ab8245, Abcam, USA), at 4°C overnight.

    Techniques: Expressing, Western Blot

    Knockdown of Ifitm1, 2, and 3 by siRNAs blocks myogenic differentiation in C2C12 cells. (A) Microscopic images of Giemsa staining for C2C12 myoblasts on day 3 of myogenic differentiation after transfection with siRNAs targeting Ifitm1-3. Two different siRNAs were used for each targeting gene. Transfection without siRNAs, but with transfection reagent was set as mock. Magnification: 100×. (B) Percentage fusion on day 3 of myogenic induction and transfection with siRNAs as described above, calculated by dividing the number of nuclei within multinucleated myofibers by the total number of nuclei. NC represents the group without siRNAs and transfection reagents. (C) Downregulated protein expression of myogenin, MyoD, Myf5, and desmin after interference by siRNAs targeting Ifitm1-3. (D) Quantification of band intensity as described above is shown. The level of proteins was normalized to that of GAPDH. Statistical significance: *P< 0.05; **P < 0.01; ***P < 0.001; NS, not significant.

    Journal: Intractable & Rare Diseases Research

    Article Title: The novel role of IFITM1-3 in myogenic differentiation of C2C12 cells

    doi: 10.5582/irdr.2023.01050

    Figure Lengend Snippet: Knockdown of Ifitm1, 2, and 3 by siRNAs blocks myogenic differentiation in C2C12 cells. (A) Microscopic images of Giemsa staining for C2C12 myoblasts on day 3 of myogenic differentiation after transfection with siRNAs targeting Ifitm1-3. Two different siRNAs were used for each targeting gene. Transfection without siRNAs, but with transfection reagent was set as mock. Magnification: 100×. (B) Percentage fusion on day 3 of myogenic induction and transfection with siRNAs as described above, calculated by dividing the number of nuclei within multinucleated myofibers by the total number of nuclei. NC represents the group without siRNAs and transfection reagents. (C) Downregulated protein expression of myogenin, MyoD, Myf5, and desmin after interference by siRNAs targeting Ifitm1-3. (D) Quantification of band intensity as described above is shown. The level of proteins was normalized to that of GAPDH. Statistical significance: *P< 0.05; **P < 0.01; ***P < 0.001; NS, not significant.

    Article Snippet: The membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.1% Tween 20 (TBST) for 2 h at room temperature, and then the membranes were incubated with primary antibodies, namely, rabbit anti-desmin (ab32362, Abcam, USA), rabbit anti-MyoD (ab203383, Abcam, USA), rabbit anti-MYF5 (ab125301, Abcam, USA), rabbit anti-IFITM1 (bs-1031R, Bioss, China), rabbit anti-IFITM2 (bs-15517R, Bioss, China), mouse anti-IFITM3 (bsm-51629M, Bioss, China), and rabbit anti-GAPDH (ab8245, Abcam, USA), at 4°C overnight.

    Techniques: Staining, Transfection, Expressing

    Identification and validation of IFITM1,3-interacting proteins. (A) Principle of co-immunoprecipitation and liquid chromatography combined with tandem mass spectrometry (LC-MS/MS). (B) The protein- protein interaction network if IFITM1,3 (overlapped) revealed by STRING analysis. A total of 84 unique homologous proteins are shown in the network. Three clusters are indicated in different colors. Cluster 1: muscle filament sliding (green color); Cluster 2: ribosome series proteins (red color); Cluster 3: regulation of mRNA metabolic process (blue color). Associations are represented by the lines. Thicker lines represent stronger associations. (C) Co-IP assays show the interaction between desmin and IFITM1, 3.

    Journal: Intractable & Rare Diseases Research

    Article Title: The novel role of IFITM1-3 in myogenic differentiation of C2C12 cells

    doi: 10.5582/irdr.2023.01050

    Figure Lengend Snippet: Identification and validation of IFITM1,3-interacting proteins. (A) Principle of co-immunoprecipitation and liquid chromatography combined with tandem mass spectrometry (LC-MS/MS). (B) The protein- protein interaction network if IFITM1,3 (overlapped) revealed by STRING analysis. A total of 84 unique homologous proteins are shown in the network. Three clusters are indicated in different colors. Cluster 1: muscle filament sliding (green color); Cluster 2: ribosome series proteins (red color); Cluster 3: regulation of mRNA metabolic process (blue color). Associations are represented by the lines. Thicker lines represent stronger associations. (C) Co-IP assays show the interaction between desmin and IFITM1, 3.

    Article Snippet: The membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.1% Tween 20 (TBST) for 2 h at room temperature, and then the membranes were incubated with primary antibodies, namely, rabbit anti-desmin (ab32362, Abcam, USA), rabbit anti-MyoD (ab203383, Abcam, USA), rabbit anti-MYF5 (ab125301, Abcam, USA), rabbit anti-IFITM1 (bs-1031R, Bioss, China), rabbit anti-IFITM2 (bs-15517R, Bioss, China), mouse anti-IFITM3 (bsm-51629M, Bioss, China), and rabbit anti-GAPDH (ab8245, Abcam, USA), at 4°C overnight.

    Techniques: Immunoprecipitation, Liquid Chromatography, Mass Spectrometry, Liquid Chromatography with Mass Spectroscopy, Co-Immunoprecipitation Assay

    Overlapped interacted proteins for  IFITM1  and IFITM3

    Journal: Intractable & Rare Diseases Research

    Article Title: The novel role of IFITM1-3 in myogenic differentiation of C2C12 cells

    doi: 10.5582/irdr.2023.01050

    Figure Lengend Snippet: Overlapped interacted proteins for IFITM1 and IFITM3

    Article Snippet: The membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.1% Tween 20 (TBST) for 2 h at room temperature, and then the membranes were incubated with primary antibodies, namely, rabbit anti-desmin (ab32362, Abcam, USA), rabbit anti-MyoD (ab203383, Abcam, USA), rabbit anti-MYF5 (ab125301, Abcam, USA), rabbit anti-IFITM1 (bs-1031R, Bioss, China), rabbit anti-IFITM2 (bs-15517R, Bioss, China), mouse anti-IFITM3 (bsm-51629M, Bioss, China), and rabbit anti-GAPDH (ab8245, Abcam, USA), at 4°C overnight.

    Techniques:

    GO and KEGG pathway enrichment analysis of 84 proteins that interact with IFITM1, 3 (overlapped). (A) KEGG classification map of differentially expressed genes. The y-axis shows the metabolic pathway. (B) Biological process (BP). (C) Cellular component (CC). (D) Molecular function (MF). The x-axis represents gene ratio = count/set size. Dot size represents the number of genes, and the color bar represents the Padj-value.

    Journal: Intractable & Rare Diseases Research

    Article Title: The novel role of IFITM1-3 in myogenic differentiation of C2C12 cells

    doi: 10.5582/irdr.2023.01050

    Figure Lengend Snippet: GO and KEGG pathway enrichment analysis of 84 proteins that interact with IFITM1, 3 (overlapped). (A) KEGG classification map of differentially expressed genes. The y-axis shows the metabolic pathway. (B) Biological process (BP). (C) Cellular component (CC). (D) Molecular function (MF). The x-axis represents gene ratio = count/set size. Dot size represents the number of genes, and the color bar represents the Padj-value.

    Article Snippet: The membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.1% Tween 20 (TBST) for 2 h at room temperature, and then the membranes were incubated with primary antibodies, namely, rabbit anti-desmin (ab32362, Abcam, USA), rabbit anti-MyoD (ab203383, Abcam, USA), rabbit anti-MYF5 (ab125301, Abcam, USA), rabbit anti-IFITM1 (bs-1031R, Bioss, China), rabbit anti-IFITM2 (bs-15517R, Bioss, China), mouse anti-IFITM3 (bsm-51629M, Bioss, China), and rabbit anti-GAPDH (ab8245, Abcam, USA), at 4°C overnight.

    Techniques:

    Pseudo-time analysis of KC and impaired epidermal differentiation in DFU. ( a ) Pseudo-temporal cells ordering of the total KC along the differentiation trajectory. ( b ) Pseudo-temporal cell ordering of KC in AW along the differentiation trajectory. ( c ) Pseudo-temporal cell ordering of the KC in the DFU along the differentiation trajectory. The pseudo-time data are depicted in dark purple to light yellow ( d ) The expression levels of the marker genes COL17A1, KRT14, FOS, IFITM1, S100A7, KRT6C, KRT1, and KRT10 along the pseudo-time trajectory. ( e ) UMAP analysis of the cell cycle distribution of KC at different stages. The cells are colored by type and annotated in the graph. ( f ) S score of each KC cluster. ( g ) G2M. Score of each KC cluster. * p -value <0.05. ( h ) Gene scoring analysis of the molecular signatures, including the Q score, diff score and inflammatory score. * p <0.05, ** p e <0.01, (ns) p >0.05. ( i ) Schematic of epidermal cell differentiation trajectories in AW and DFU. Quiescent score (Q score), differentiated score (diff score), basal cells (BC), diabetes-associated keratinocytes (DAK), and differentiated keratinocytes (diff-KC)

    Journal: Burns & Trauma

    Article Title: Single-cell RNA sequencing reveals the impaired epidermal differentiation and pathological microenvironment in diabetic foot ulcer

    doi: 10.1093/burnst/tkae065

    Figure Lengend Snippet: Pseudo-time analysis of KC and impaired epidermal differentiation in DFU. ( a ) Pseudo-temporal cells ordering of the total KC along the differentiation trajectory. ( b ) Pseudo-temporal cell ordering of KC in AW along the differentiation trajectory. ( c ) Pseudo-temporal cell ordering of the KC in the DFU along the differentiation trajectory. The pseudo-time data are depicted in dark purple to light yellow ( d ) The expression levels of the marker genes COL17A1, KRT14, FOS, IFITM1, S100A7, KRT6C, KRT1, and KRT10 along the pseudo-time trajectory. ( e ) UMAP analysis of the cell cycle distribution of KC at different stages. The cells are colored by type and annotated in the graph. ( f ) S score of each KC cluster. ( g ) G2M. Score of each KC cluster. * p -value <0.05. ( h ) Gene scoring analysis of the molecular signatures, including the Q score, diff score and inflammatory score. * p <0.05, ** p e <0.01, (ns) p >0.05. ( i ) Schematic of epidermal cell differentiation trajectories in AW and DFU. Quiescent score (Q score), differentiated score (diff score), basal cells (BC), diabetes-associated keratinocytes (DAK), and differentiated keratinocytes (diff-KC)

    Article Snippet: Dewaxed paraffin skin sections were subjected to heat-mediated antigen retrieval (citrate buffer; pH = 6) and labeled with a rabbit polyclonal antibody against IL1R2 (1: 1000; DF6682, Affinity Biosciences), a mouse monoclonal antibody against TXNIP (1: 1000; ab210826, Abcam), a rabbit monoclonal antibody against KRT15 (1: 1000; ab52816, Abcam), a rabbit monoclonal antibody against SH3KBP1 Ab (1: 1000; Ab151574, Abcam), a rabbit monoclonal antibody against GRP (1: 1000; ab236050, Abcam), a rabbit monoclonal antibody against KRT10 (1: 1000; ab76318, Abcam), a rabbit polyclonal antibody against IFITM1 (1: 100; DF2513, Affinity Biosciences), and a rabbit polyclonal antibody against IFITM3 (1: 100; DF8270, Affinity Biosciences).

    Techniques: Expressing, Marker, Cell Differentiation

    Upregulation of IFITMs in HTR8/SVneo cells following IFN-β treatment was evaluated by western blot and immunofluorescence IFN-β inhibits invasion of HTR8/SVneo cells (A–E) and primary human EVCTs (F–I). HTR8/SVneo cells and EVCTs were incubated for 48 h with IFN-β (10, 100, or 1000 IU/mL). (A) Cell lysates (40 μg) were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for IFITM1, IFITM2/3, and vinculin expression. One representative experiment (out of 3) is shown. (B) Representative image of HTR8/SVneo cells immunostained for cytokeratin 7 (marker of trophoblast, magenta) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bars: 10 μm. Inhibition of HTR8/SVneo cell invasion following IFN-β treatment , quantified using IncuCyte technology (C–E) . HTR8/SVneo cells were cultured in a monolayer in 96-well plates. Cells were treated for 48 h, then a wound was made using a 96-well wound maker; this was covered by Matrigel and cells were imaged with Incucyte every 30 min for 48 h. (C) Representative images of HTR8/SVneo cell invasion at 48 h. The blue region denotes the area of the initial wound (light blue line) covered by advancing cells. (D) Time course of wound closure expressed as relative wound density (%). Values are reported as mean ± SEM. (E) Comparison between vehicle and IFN-β-treated cells was performed using an analysis of the area under the curve of the replicates represented in (D). Values are reported as mean + SEM (n = 6 wells/condition, n = 3 experiments). Statistical analysis was performed with one-way ANOVA to compare treatment to vehicle controls. ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. Upregulation of IFITMs in EVCTs following IFN-β treatment was evaluated by western blot (F) and immunofluorescence (G) . (F) Cell lysates (40 μg) from isolated EVCTs were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for IFITM1, IFITM2/3, and vinculin expression. One representative experiment (out of 3) is shown. (G) Representative image of isolated EVCTs and placental explants immunostained for cytokeratin 7 (marker of trophoblast, magenta) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bars: 10 μm. Inhibition of EVCT invasion following IFN-β treatment using villous explant culture model (H–I) . (H) Representative image of extravillous explants cultured on Matrigel and immunostained for integrin α5 (ITGA5, marker of invasion, red). Scale bars: 100 μm. (I) Statistical analysis of the invasion distance of ITGA5 + EVCTs, as representatively shown in H. Values are presented as mean + SD (n = 3 explants per condition, n = 3 placentas). One-way ANOVA was performed to compare treatment to vehicle control; ∗∗∗∗p < 0.0001.

    Journal: iScience

    Article Title: IFITM1 inhibits trophoblast invasion and is induced in placentas associated with IFN-mediated pregnancy diseases

    doi: 10.1016/j.isci.2023.107147

    Figure Lengend Snippet: Upregulation of IFITMs in HTR8/SVneo cells following IFN-β treatment was evaluated by western blot and immunofluorescence IFN-β inhibits invasion of HTR8/SVneo cells (A–E) and primary human EVCTs (F–I). HTR8/SVneo cells and EVCTs were incubated for 48 h with IFN-β (10, 100, or 1000 IU/mL). (A) Cell lysates (40 μg) were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for IFITM1, IFITM2/3, and vinculin expression. One representative experiment (out of 3) is shown. (B) Representative image of HTR8/SVneo cells immunostained for cytokeratin 7 (marker of trophoblast, magenta) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bars: 10 μm. Inhibition of HTR8/SVneo cell invasion following IFN-β treatment , quantified using IncuCyte technology (C–E) . HTR8/SVneo cells were cultured in a monolayer in 96-well plates. Cells were treated for 48 h, then a wound was made using a 96-well wound maker; this was covered by Matrigel and cells were imaged with Incucyte every 30 min for 48 h. (C) Representative images of HTR8/SVneo cell invasion at 48 h. The blue region denotes the area of the initial wound (light blue line) covered by advancing cells. (D) Time course of wound closure expressed as relative wound density (%). Values are reported as mean ± SEM. (E) Comparison between vehicle and IFN-β-treated cells was performed using an analysis of the area under the curve of the replicates represented in (D). Values are reported as mean + SEM (n = 6 wells/condition, n = 3 experiments). Statistical analysis was performed with one-way ANOVA to compare treatment to vehicle controls. ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. Upregulation of IFITMs in EVCTs following IFN-β treatment was evaluated by western blot (F) and immunofluorescence (G) . (F) Cell lysates (40 μg) from isolated EVCTs were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for IFITM1, IFITM2/3, and vinculin expression. One representative experiment (out of 3) is shown. (G) Representative image of isolated EVCTs and placental explants immunostained for cytokeratin 7 (marker of trophoblast, magenta) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bars: 10 μm. Inhibition of EVCT invasion following IFN-β treatment using villous explant culture model (H–I) . (H) Representative image of extravillous explants cultured on Matrigel and immunostained for integrin α5 (ITGA5, marker of invasion, red). Scale bars: 100 μm. (I) Statistical analysis of the invasion distance of ITGA5 + EVCTs, as representatively shown in H. Values are presented as mean + SD (n = 3 explants per condition, n = 3 placentas). One-way ANOVA was performed to compare treatment to vehicle control; ∗∗∗∗p < 0.0001.

    Article Snippet: Rabbit anti-IFITM1 polyclonal antibody , Sigma-Aldrich , Cat# HPA004810; RRID: AB_1851419.

    Techniques: Western Blot, Immunofluorescence, Incubation, SDS Page, Expressing, Marker, Inhibition, Cell Culture, Isolation

    Ectopic expression of FLAG and IFITMs in HTR8/SVneo cells transduced with IFITM1–3 was verified by western blot, immunofluorescence, and flow cytometry IFITM1 inhibits invasion of HTR8/SVneo cells (A–E) and primary human EVCTs. (A) Cell lysates (40 μg) were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for IFITM1, IFITM2/3, and vinculin expression. A representative experiment is shown. (B) Representative image of transduced HTR8/SVneo cells immunostained for FLAG (yellow) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bar: 10 μm. (C) HTR8/SVneo cells transduced with a vector containing IFITM1 (green), IFITM2 (orange), IFITM3 (magenta), or a control empty vector (dark blue) were stained with antibodies for IFITM1, IFITM2/3, and FLAG, as well as corresponding isotypes. Cells were then analyzed by flow cytometry. Inhibition of IFITM1-transduced HTR8/SVneo cell invasion , quantified using IncuCyte technology (D–F) . HTR8/SVneo cells transduced with IFITM1–3 were cultured in a monolayer in 96-well plates and a wound was made using a 96-well wound maker; this was covered by Matrigel and cells were imaged with Incucyte every 30 min for 48 h. (D) Representative images of transduced HTR8/SVneo cell invasion at 48 h. The blue region denotes the area of the initial wound (light blue line) covered by advancing cells. (E) Time course of wound closure expressed as relative wound density (%). Values are reported as mean ± SEM of the percentage. (F) Comparison between cells transduced with IFITM1–3 and the empty vector was performed using an analysis of the area under the curve of the replicates represented in (E). Values are represented as mean + SEM (n = 6 wells/condition, n = 3 experiments). Statistical analysis was performed with one-way ANOVA to compare treatment to vehicle controls. ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. Ectopic expression of GFP , FLAG , and IFITMs in EVCT explants transduced with IFITM1–3 was verified by immunofluorescence (G–J) . (G) Representative image of placental explants transduced with GFP or IFITM1–3, cultured on Matrigel, and immunostained for FLAG (yellow), GFP (green), and IFITM1 (red) or IFITM2/3 (magenta), and then counterstained with DAPI (blue). Scale bars: 100 μm. (H) Representative image of EVCT explants transduced with GFP or IFITM1–3, cultured on Matrigel, and immunostained for FLAG (yellow), GFP (green), and ITGA5 (red) or HLAG (magenta), and then counterstained with DAPI (blue). Scale bars: 100 μm. Inhibition of IFITM1-transduced EVCT invasion using villous explant culture model (I–J) . (I) Representative image of transduced extravillous explants cultured on Matrigel and immunostained for integrin α5 (ITGA5, marker of invasion, red). Scale bars: 100 μm. (J) Statistical analysis of the invasion distance of ITGA5 + EVCTs, as representatively shown in I. Values are presented as mean + SD (n = 3 explants per condition, n = 3 placentas). One-way ANOVA was performed to compare treatment to pTRIP-GFP control; ∗∗∗∗p < 0.0001.

    Journal: iScience

    Article Title: IFITM1 inhibits trophoblast invasion and is induced in placentas associated with IFN-mediated pregnancy diseases

    doi: 10.1016/j.isci.2023.107147

    Figure Lengend Snippet: Ectopic expression of FLAG and IFITMs in HTR8/SVneo cells transduced with IFITM1–3 was verified by western blot, immunofluorescence, and flow cytometry IFITM1 inhibits invasion of HTR8/SVneo cells (A–E) and primary human EVCTs. (A) Cell lysates (40 μg) were loaded in 4–15% SDS-PAGE gradient gels and blots were probed for IFITM1, IFITM2/3, and vinculin expression. A representative experiment is shown. (B) Representative image of transduced HTR8/SVneo cells immunostained for FLAG (yellow) and IFITM1 (green) or IFITM2/3 (red), and then counterstained with DAPI (blue). Scale bar: 10 μm. (C) HTR8/SVneo cells transduced with a vector containing IFITM1 (green), IFITM2 (orange), IFITM3 (magenta), or a control empty vector (dark blue) were stained with antibodies for IFITM1, IFITM2/3, and FLAG, as well as corresponding isotypes. Cells were then analyzed by flow cytometry. Inhibition of IFITM1-transduced HTR8/SVneo cell invasion , quantified using IncuCyte technology (D–F) . HTR8/SVneo cells transduced with IFITM1–3 were cultured in a monolayer in 96-well plates and a wound was made using a 96-well wound maker; this was covered by Matrigel and cells were imaged with Incucyte every 30 min for 48 h. (D) Representative images of transduced HTR8/SVneo cell invasion at 48 h. The blue region denotes the area of the initial wound (light blue line) covered by advancing cells. (E) Time course of wound closure expressed as relative wound density (%). Values are reported as mean ± SEM of the percentage. (F) Comparison between cells transduced with IFITM1–3 and the empty vector was performed using an analysis of the area under the curve of the replicates represented in (E). Values are represented as mean + SEM (n = 6 wells/condition, n = 3 experiments). Statistical analysis was performed with one-way ANOVA to compare treatment to vehicle controls. ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. Ectopic expression of GFP , FLAG , and IFITMs in EVCT explants transduced with IFITM1–3 was verified by immunofluorescence (G–J) . (G) Representative image of placental explants transduced with GFP or IFITM1–3, cultured on Matrigel, and immunostained for FLAG (yellow), GFP (green), and IFITM1 (red) or IFITM2/3 (magenta), and then counterstained with DAPI (blue). Scale bars: 100 μm. (H) Representative image of EVCT explants transduced with GFP or IFITM1–3, cultured on Matrigel, and immunostained for FLAG (yellow), GFP (green), and ITGA5 (red) or HLAG (magenta), and then counterstained with DAPI (blue). Scale bars: 100 μm. Inhibition of IFITM1-transduced EVCT invasion using villous explant culture model (I–J) . (I) Representative image of transduced extravillous explants cultured on Matrigel and immunostained for integrin α5 (ITGA5, marker of invasion, red). Scale bars: 100 μm. (J) Statistical analysis of the invasion distance of ITGA5 + EVCTs, as representatively shown in I. Values are presented as mean + SD (n = 3 explants per condition, n = 3 placentas). One-way ANOVA was performed to compare treatment to pTRIP-GFP control; ∗∗∗∗p < 0.0001.

    Article Snippet: Rabbit anti-IFITM1 polyclonal antibody , Sigma-Aldrich , Cat# HPA004810; RRID: AB_1851419.

    Techniques: Expressing, Transduction, Western Blot, Immunofluorescence, Flow Cytometry, SDS Page, Plasmid Preparation, Staining, Inhibition, Cell Culture, Marker

    Induction of IFITM1 expression in placental tissues from IFN-induced pathologies of pregnancy (A) Representative images of CK7, IFITM1, and HLAG immunostaining and HES staining in placental tissues from CMV- and bacterial-infected patients (left panel) and non-infected controls (right panel). Yellow asterisks represent EVCTs (CK7+, HLGA+). Scale bars: 200 μm. The insets depict a higher magnification of EVCT labeling. Scale bar: 20 μm. (B) Quantification of IFITM1 protein expression in EVCTs from CMV- and bacterial-infected and non-infected control pregnancies at three different weeks of gestation (19, 24, and 34 WG, n = 1 per condition, 25 non-overlapping ROIs per placenta). (C) Statistical analyses of IFITM1 protein expression of data shown in B combined by all gestational ages per (n = 3 placentas (19, 24, and 34 WG) per condition (CMV- or bacterial-infected and non-infected), 75 non-overlapping ROIs per condition). Values are presented as mean + SD. One-way ANOVA was performed to compare infected to non-infected controls; ∗∗∗∗p < 0.0001.

    Journal: iScience

    Article Title: IFITM1 inhibits trophoblast invasion and is induced in placentas associated with IFN-mediated pregnancy diseases

    doi: 10.1016/j.isci.2023.107147

    Figure Lengend Snippet: Induction of IFITM1 expression in placental tissues from IFN-induced pathologies of pregnancy (A) Representative images of CK7, IFITM1, and HLAG immunostaining and HES staining in placental tissues from CMV- and bacterial-infected patients (left panel) and non-infected controls (right panel). Yellow asterisks represent EVCTs (CK7+, HLGA+). Scale bars: 200 μm. The insets depict a higher magnification of EVCT labeling. Scale bar: 20 μm. (B) Quantification of IFITM1 protein expression in EVCTs from CMV- and bacterial-infected and non-infected control pregnancies at three different weeks of gestation (19, 24, and 34 WG, n = 1 per condition, 25 non-overlapping ROIs per placenta). (C) Statistical analyses of IFITM1 protein expression of data shown in B combined by all gestational ages per (n = 3 placentas (19, 24, and 34 WG) per condition (CMV- or bacterial-infected and non-infected), 75 non-overlapping ROIs per condition). Values are presented as mean + SD. One-way ANOVA was performed to compare infected to non-infected controls; ∗∗∗∗p < 0.0001.

    Article Snippet: Rabbit anti-IFITM1 polyclonal antibody , Sigma-Aldrich , Cat# HPA004810; RRID: AB_1851419.

    Techniques: Expressing, Immunostaining, Staining, Infection, Labeling

    Journal: iScience

    Article Title: IFITM1 inhibits trophoblast invasion and is induced in placentas associated with IFN-mediated pregnancy diseases

    doi: 10.1016/j.isci.2023.107147

    Figure Lengend Snippet:

    Article Snippet: Rabbit anti-IFITM1 polyclonal antibody , Sigma-Aldrich , Cat# HPA004810; RRID: AB_1851419.

    Techniques: Recombinant, Electron Microscopy, Selection, Bicinchoninic Acid Protein Assay, Plasmid Preparation, Software